Tyra Biosciences Revenue and Competitors

Location

#3441

Growjo Ranking

Biotech

Industry

Estimated Revenue & Valuation

  • Tyra Biosciences's estimated annual revenue is currently $4M per year.(i)
  • Tyra Biosciences's estimated revenue per employee is $63,968
  • Tyra Biosciences's current valuation is $514.2M. (January 2022)

Employee Data

  • Tyra Biosciences has 63 Employees.(i)
  • Tyra Biosciences grew their employee count by 37% last year.

Tyra Biosciences's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
VP Translational and Data SciencesReveal Email/Phone
3
VP, Corporate Development and StrategyReveal Email/Phone
4
VP Clinical Sciences and OperationsReveal Email/Phone
5
VP QualityReveal Email/Phone
6
General Counsel and SecretaryReveal Email/Phone
7
VP, Clinical Development and Medical AffairsReveal Email/Phone
8
VP Regulatory AffairsReveal Email/Phone
9
VP, Regulatory AffairsReveal Email/Phone
10
Chief Medical OfficerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.4M57-8%$53MN/A
#2
$21.2M137-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.3M1515%N/AN/A
#5
$1.6M10-17%N/AN/A
#6
$0.7M950%N/AN/A
#7
$11.5M74-12%N/AN/A
#8
$0.4M27510%$236.7MN/A
#9
$4M51-74%$160MN/A
#10
$2.3M1515%N/AN/A
Add Company

What Is Tyra Biosciences?

keywords:N/A

N/A

Total Funding

63

Number of Employees

$4M

Revenue (est)

37%

Employee Growth %

$514.2M

Valuation

N/A

Accelerator

Tyra Biosciences News

2022-04-20 - Form DEF 14A Tyra Biosciences, Inc. For: Jun 13

2022 ANNUAL MEETING OF STOCKHOLDERS. June 13, 2022. TYRA BIOSCIENCES, INC. 2656 State Street. Carlsbad, California 92008. April 28, 2022.

2022-03-22 - Here's Why We're Not Too Worried About Tyra Biosciences' (NASDAQ:TYRA) Cash Burn Situation

When Tyra Biosciences last reported its balance sheet in December 2021, it had zero debt and cash worth US$302m. In the last year, its cash burn...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$8.5M6321%N/A
#2
$8.5M6311%N/A
#3
$8.5M63N/AN/A
#4
$13.9M6331%N/A
#5
$14.4M633%N/A